Healthy Lifestyle Score and Incidence of Glaucoma: The Sun Project.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Feb 2022
Historique:
received: 31 12 2021
revised: 31 01 2022
accepted: 08 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 3 3 2022
Statut: epublish

Résumé

The relationship between modifiable risk factors, such as diet and lifestyle, and glaucoma remains controversial. We analyse the effect of the Mediterranean lifestyle (ML) on glaucoma incidence in the "Seguimiento Universidad de Navarra" (SUN) Project. The SUN Healthy Lifestyle Score (SHLS) includes 10 healthy habits: never having smoked, moderate to high physical activity, Mediterranean diet adherence, moderate alcohol consumption, low television exposure, no binge drinking, short afternoon napping, meeting up with friends, working at least 40 h/wk, and low body mass index. The information was collected biennially through self-reported questionnaires. The relationship between new glaucoma cases and the SHLS was assessed by Cox regression using hazard ratios. Crude, multi-adjusted, and sensitivity analyses were performed. During a median of 12 years of follow-up, 261 (1.42%) new cases of glaucoma were identified among 18,420 participants. After adjusting for potential confounders, participants in the healthiest SHLS category showed a significantly reduced risk of glaucoma compared to those in the lowest SHLS category (adjusted HR = 0.51, 95% CI = 0.28-0.93). For each point added to the SHLS, the risk of glaucoma relatively dropped 5%. Higher adherence to a ML, measured by the SHLS, was significantly associated with a lower risk of developing glaucoma. Based on our study, the ML is a protective factor for glaucoma incidence.

Sections du résumé

BACKGROUND BACKGROUND
The relationship between modifiable risk factors, such as diet and lifestyle, and glaucoma remains controversial. We analyse the effect of the Mediterranean lifestyle (ML) on glaucoma incidence in the "Seguimiento Universidad de Navarra" (SUN) Project.
METHODS METHODS
The SUN Healthy Lifestyle Score (SHLS) includes 10 healthy habits: never having smoked, moderate to high physical activity, Mediterranean diet adherence, moderate alcohol consumption, low television exposure, no binge drinking, short afternoon napping, meeting up with friends, working at least 40 h/wk, and low body mass index. The information was collected biennially through self-reported questionnaires. The relationship between new glaucoma cases and the SHLS was assessed by Cox regression using hazard ratios. Crude, multi-adjusted, and sensitivity analyses were performed.
RESULTS RESULTS
During a median of 12 years of follow-up, 261 (1.42%) new cases of glaucoma were identified among 18,420 participants. After adjusting for potential confounders, participants in the healthiest SHLS category showed a significantly reduced risk of glaucoma compared to those in the lowest SHLS category (adjusted HR = 0.51, 95% CI = 0.28-0.93). For each point added to the SHLS, the risk of glaucoma relatively dropped 5%.
CONCLUSIONS CONCLUSIONS
Higher adherence to a ML, measured by the SHLS, was significantly associated with a lower risk of developing glaucoma. Based on our study, the ML is a protective factor for glaucoma incidence.

Identifiants

pubmed: 35215429
pii: nu14040779
doi: 10.3390/nu14040779
pmc: PMC8879768
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : RD16/0008
Organisme : Advanced Research Grant of the European Research Council
ID : 340918
Organisme : Instituto de Salud Carlos III
ID : (RD 06/0045, CIBER-OBN, Grants PI13/00615, PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795 and G03/140)
Organisme : Comunidad Foral de Navarra
ID : (27/2011, 45/2011, 122/2014)

Références

J Epidemiol. 2009;19(6):303-10
pubmed: 19776497
Br J Pharmacol. 2002 Oct;137(3):295-310
pubmed: 12237248
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
West J Nurs Res. 2019 Sep;41(9):1241-1253
pubmed: 30632455
Nutr Res. 2020 Mar;75:77-84
pubmed: 32045786
Eur J Public Health. 2015 Aug;25(4):683-8
pubmed: 25653298
Occup Environ Med. 2001 Sep;58(9):569-74
pubmed: 11511743
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
JAMA Ophthalmol. 2016 Mar;134(3):294-303
pubmed: 26767881
Circulation. 2018 Jul 24;138(4):345-355
pubmed: 29712712
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):902-904
pubmed: 29684102
Ophthalmology. 2014 Jul;121(7):1370-6
pubmed: 24650554
Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):624-632
pubmed: 28684083
Am J Ophthalmol. 2012 Aug;154(2):315-325.e1
pubmed: 22541649
Nutr Metab Cardiovasc Dis. 2015 Jan;25(1):60-7
pubmed: 25315667
Vestn Oftalmol. 2001 Sep-Oct;117(5):34-7
pubmed: 11765466
J Glaucoma. 2005 Oct;14(5):384-6
pubmed: 16148587
Medicine (Baltimore). 2017 Jan;96(1):e5761
pubmed: 28072720
Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):993-995
pubmed: 30037536
JAMA. 2019 Aug 6;322(5):430-437
pubmed: 31302669
Circulation. 2002 Jun 18;105(24):2836-44
pubmed: 12070110
Int J Epidemiol. 2006 Dec;35(6):1417-22
pubmed: 17060332
Diabetologia. 2013 Nov;56(11):2405-13
pubmed: 23975324
Clin Nutr. 2014 Dec;33(6):1041-5
pubmed: 24290344
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Heart. 2016 Jul 1;102(13):1009-16
pubmed: 27091846
Arch Intern Med. 2009 Apr 27;169(8):764-70
pubmed: 19398688
Circulation. 2006 Jul 11;114(2):160-7
pubmed: 16818808
J Optom. 2017 Apr - Jun;10(2):71-78
pubmed: 27025415
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):929-39
pubmed: 24787907
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Nutrients. 2018 Dec 30;11(1):
pubmed: 30598006
Nutrients. 2015 Nov 05;7(11):9116-26
pubmed: 26556367
N Engl J Med. 2010 Dec 2;363(23):2211-9
pubmed: 21121834
Eur J Clin Nutr. 2019 Jul;72(Suppl 1):1-3
pubmed: 30487557
Prog Retin Eye Res. 2021 Jul;83:100922
pubmed: 33253900
Am J Epidemiol. 2012 Oct 1;176(7):586-96
pubmed: 22952309
Pathophysiology. 2017 Sep;24(3):123-131
pubmed: 28629694
Acta Ophthalmol Scand. 2001 Dec;79(6):560-6
pubmed: 11782219
Eur J Clin Nutr. 2008 May;62(5):651-9
pubmed: 17440519
Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):1001-1009
pubmed: 29287797
PLoS One. 2017 Mar 8;12(3):e0172253
pubmed: 28273154
Exp Eye Res. 2017 Apr;157:20-27
pubmed: 28242160
Surv Ophthalmol. 2013 Jul-Aug;58(4):311-20
pubmed: 23768921
J Nutr. 2015 Jul;145(7):1531-40
pubmed: 25948783
Alcohol. 2019 May;76:117-129
pubmed: 30735906
Atherosclerosis. 2017 Aug;263:151-155
pubmed: 28645071
Nutr Rev. 1997 Nov;55(11 Pt 1):383-9
pubmed: 9420448
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
JAMA. 2004 Sep 22;292(12):1433-9
pubmed: 15383513
Saudi J Ophthalmol. 2020 Nov 22;34(1):45-49
pubmed: 33542987
Nitric Oxide. 2018 Jul 1;77:75-87
pubmed: 29723581
Am J Epidemiol. 2014 May 1;179(9):1115-24
pubmed: 24685532
Nutrients. 2020 Oct 16;12(10):
pubmed: 33081127
Lancet. 1998 May 30;351(9116):1603-8
pubmed: 9620713

Auteurs

Javier Moreno-Montañés (J)

Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31008 Pamplona, Spain.

Elsa Gándara (E)

Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.

Itziar Gutierrez-Ruiz (I)

Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.

Laura Moreno-Galarraga (L)

IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31008 Pamplona, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Department of Pediatrics, Complejo Hospitalario de Navarra, Servicio Navarro de Salud, 31008 Pamplona, Spain.

Miguel Ruiz-Canela (M)

IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31008 Pamplona, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBER Obn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Maira Bes-Rastrollo (M)

IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31008 Pamplona, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBER Obn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Miguel Ángel Martínez-González (MÁ)

IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31008 Pamplona, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBER Obn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.

Alejandro Fernandez-Montero (A)

IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31008 Pamplona, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Department of Occupational Medicine, University of Navarra, 31008 Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH